His areas of research interest include clinical pharmacokinetics and PK/PD modeling. He is currently working on the pathophysiology and treatment of depression and addiction. His previous research focused on pharmacodynamic (PD) modeling of various control mechanisms involved in the delayed onset of therapeutic action of selective serotonin reuptake inhibitors (SSRIs).